Etienne Chatelut

Etienne Chatelut

UNVERIFIED PROFILE

Are you Etienne Chatelut?   Register this Author

Register author
Etienne Chatelut

Etienne Chatelut

Publications by authors named "Etienne Chatelut"

Are you Etienne Chatelut?   Register this Author

100Publications

3152Reads

5Profile Views

Involvement of Pazopanib and Sunitinib Aldehyde Reactive Metabolites in Toxicity and Drug-Drug Interactions and in Patient Samples.

Chem Res Toxicol 2019 Sep 26. Epub 2019 Sep 26.

Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037 , Université de Toulouse , 2 Avenue Hubert Curien, CS53717 , 31037 Toulouse , Cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.chemrestox.9b00205DOI Listing
September 2019

A fast UPLC-HILIC method for an accurate quantification of dendrogenin A in human tissues.

J Steroid Biochem Mol Biol 2019 Aug 12;194:105447. Epub 2019 Aug 12.

Team "Dose individualization of anticancer drugs », Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France; Institut Claudius Regaud, Institut Universitaire du Cancer-Oncopole, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2019.105447DOI Listing
August 2019

Identifying the reactive metabolites of tyrosine kinase inhibitors in a comprehensive approach: Implications for drug-drug interactions and hepatotoxicity.

Med Res Rev 2019 May 20. Epub 2019 May 20.

Centre de Recherches en Cancérologie de Toulouse, INSERMUMR1037, Université de Toulouse, Toulouse Cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/med.21577DOI Listing
May 2019

Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib.

Clin Pharmacokinet 2019 Apr;58(4):451-467

UMR8638 CNRS, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40262-018-0703-0
Publisher Site
http://dx.doi.org/10.1007/s40262-018-0703-0DOI Listing
April 2019

Pharmacodynamic Therapeutic Drug Monitoring for Cancer: Challenges, Advances, and Future Opportunities.

Ther Drug Monit 2019 04;41(2):142-159

Institut Claudius-Regaud and Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000606DOI Listing
April 2019

Evaluation of the Interaction of Amino Acid Infusion on Lu-Dotatate Pharmacokinetics in Patients with Gastroenteropancreatic Neuroendocrine Tumors.

Clin Pharmacokinet 2019 Feb;58(2):213-222

Institut Claudius-Regaud, Institut Universitaire du Cancer Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40262-018-0674-1
Publisher Site
http://dx.doi.org/10.1007/s40262-018-0674-1DOI Listing
February 2019

How can we best monitor 5-FU administration to maximize benefit to risk ratio?

Expert Opin Drug Metab Toxicol 2018 Dec 23;14(12):1303-1313. Epub 2018 Nov 23.

g Service Pharmacie , Centre Georges-François Leclerc , Dijon , France.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17425255.2018.1
Publisher Site
http://dx.doi.org/10.1080/17425255.2018.1550484DOI Listing
December 2018

Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study.

Endocr Connect 2018 Dec;7(12):1409-1414

Pharmacokinetics and Pharmacochemistry Unit, Cochin Hospital, Paris Descartes University, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EC-18-0428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301193PMC
December 2018

Efavirenz and Lopinavir Levels in HIV-Infected Women and Their Nursing Infants, in Mali.

J Pharmacol Exp Ther 2018 09 9;366(3):479-484. Epub 2018 Jul 9.

Pharmacokinetics and Toxicology Laboratory, Federative Institute of Biology, Purpan Hospital University, Toulouse, France (A.A.O., M.-C.C., P.G.); Institut National de la Sante et de la Recherche Medicale, Unité Mixte de Recherche 1037, Pharmacology and Pharmacogenetics Laboratory, University Institute of Cancer Oncopôle, Toulouse, France (A.A.O., E.C.); HIV/Tuberculosis Research and Training Center, University of Science, Techniques and Technologies, Bamako, Mali (A.A.O., A.B., M.M., S.D.); Center for Global Health, Northwestern University, Chicago, Illinois (M.M., R.L.M.); Department of Pediatric, University Hospital of Gabriel Touré, Bamako, Mali (K.B.-M., M.S.); Referral Health Center V, Bamako, Mali (Z.D.); and Institut National de la Recherche Agronomique Unité Mixte de Recherche 1331-TOXALIM, Veterinary School of Toulouse, Toulouse, France (P.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.118.249938DOI Listing
September 2018

[5-fluorouracil therapeutic drug monitoring: Update and recommendations of the STP-PT group of the SFPT and the GPCO-Unicancer].

Bull Cancer 2018 Sep 10;105(9):790-803. Epub 2018 Aug 10.

Centre Georges-François-Leclerc, service pharmacie, 1, rue Pr.-Marion, 21000 Dijon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.06.008DOI Listing
September 2018

Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: a case report.

Cancer Chemother Pharmacol 2018 08 19;82(2):361-365. Epub 2018 Jun 19.

Unité d'Onco-Hématologie Pédiatrique, Hôpital Mère-Enfant, CHU Limoges, Limoges, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3625-5DOI Listing
August 2018

Intraindividual Pharmacokinetic Variability: Focus on Small-Molecule Kinase Inhibitors.

Clin Pharmacol Ther 2018 06 1;103(6):956-958. Epub 2017 Dec 1.

University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cpt.937
Publisher Site
http://dx.doi.org/10.1002/cpt.937DOI Listing
June 2018

Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study.

Clin Lung Cancer 2018 05 21;19(3):e277-e285. Epub 2017 Nov 21.

Department of Radiation Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France; Université Paul Sabatier, Toulouse, France; INSERM U1037, Centre de Recherche Contre le Cancer de Toulouse, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.11.002DOI Listing
May 2018

Simultaneous monitoring of pazopanib and its metabolites by UPLC-MS/MS.

J Pharm Biomed Anal 2018 May 9;154:373-383. Epub 2018 Mar 9.

Team 14, CRCT, Université de Toulouse, Inserm, UPS, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07317085173289
Publisher Site
http://dx.doi.org/10.1016/j.jpba.2018.03.013DOI Listing
May 2018

Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods.

Clin Chim Acta 2018 Apr 22;479:56-65. Epub 2017 Dec 22.

Department of Pharmacokinetic and Toxicology, Toulouse University Hospital, France; INRA, Toxalim, INP-ENVT, Toulouse University, UPS, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2017.12.034DOI Listing
April 2018

Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study.

J Steroid Biochem Mol Biol 2017 05 22;169:210-218. Epub 2016 Jun 22.

Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France; University of Toulouse III, Toulouse France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2016.06.010DOI Listing
May 2017

Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?

Fundam Clin Pharmacol 2017 Apr 25;31(2):245-253. Epub 2016 Oct 25.

Laboratoire de Pharmacocinétique et de Toxicologie, Institut Fédératif de Biologie Purpan, Centre Hospitalier Universitaire, Toulouse, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/fcp.12245
Publisher Site
http://dx.doi.org/10.1111/fcp.12245DOI Listing
April 2017

Population Pharmacokinetics of Tracers: A New Tool for Medical Imaging?

Clin Pharmacokinet 2017 02;56(2):101-106

Toxalim, Université de Toulouse, INRA, ENVT, 23 chemin des Capelles, BP 8761, 31076, Toulouse cedex 3, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-016-0437-9DOI Listing
February 2017

Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients.

Pharmacol Res 2016 11 1;113(Pt A):709-718. Epub 2016 Jul 1.

Assistance Publique Hôpitaux de Paris, Unité Fonctionnelle de Pharmacocinétique et Pharmacochimie, Hôpital Cochin, 27 rue du Faubourg Saint Jacques, 75014 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2016.06.032DOI Listing
November 2016

Quinine unbound concentration is the best marker for therapeutic drug monitoring.

Therapie 2016 Oct 11;71(5):487-489. Epub 2016 Apr 11.

Pharmacokinetics and toxicology laboratory, federative institute of biology, Purpan university hospital, 31000 Toulouse, France; EA4553 pharmacology and pharmacogenetic laboratory, university institute of cancer (Oncopôle), 31000 Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.therap.2016.02.032DOI Listing
October 2016

Quinine Unbound Concentration Has to Be Used for Therapeutic Drug Monitoring.

Ther Drug Monit 2016 08;38(4):556-7

*Pharmacokinetics and Toxicology Laboratory, Federative Institute of Biology, Purpan University Hospital, Toulouse, France †Infectious Diseases Department, Purpan University Hospital, Toulouse, France ‡Parasitology Laboratory, Federative Institute of Biology, Purpan University Hospital, Toulouse, France §EA4553 Pharmacology and Pharmacogenetic Laboratory, University Institute of Cancer (Oncopôle), Toulouse, France ¶UMR1331-TOXALIM, Toulouse Veterinary School, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000304DOI Listing
August 2016

[Not Available].

Therapie 2010 May-Jun;65(3):151-5

CHRU de Tours, Université François-Rabelais, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie/2010022DOI Listing
July 2016

[Not Available].

Therapie 2010 May-Jun;65(3):157-62

CHRU de Tours, Université François-Rabelais, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie/2010021DOI Listing
July 2016

Polymorphisms in SLCO1B3 and NR1I2 as genetic determinants of hematotoxicity of carboplatin and paclitaxel combination.

Pharmacogenomics 2015 12;16(13):1439-50. Epub 2015 Aug 12.

Laboratoire de biochimie, Centre Hospitalier Universitaire (CHU) of Nîmes, Hôpital Carémeau, Nîmes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.15.84DOI Listing
June 2016

Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.

Invest New Drugs 2016 Feb 16;34(1):41-8. Epub 2015 Nov 16.

Department of Pharmacology, Institut Claudius-Regaud, IUCT-Oncopole, 1, avenue Irène Joliot-Curie, Toulouse, F-31059, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-015-0304-9DOI Listing
February 2016

Pharmacokinetic interaction between pazopanib and cisplatin regimen.

Cancer Chemother Pharmacol 2016 Feb 16;77(2):385-92. Epub 2016 Jan 16.

Institut Claudius-Regaud, IUCT-O, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2953-yDOI Listing
February 2016

Determination of plasma unbound fraction of voriconazole in patients treated with a prophylactic or a curative treatment.

Ther Drug Monit 2014 Dec;36(6):752-8

*Laboratory of Pharmacokinetics and Clinical Toxicology, Institute of Biology, University Hospital of Toulouse; and †EA4553 Laboratory of Pharmacokinetics, Claudius-Regaud Institute, Toulouse, France.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/drug-monitoring/2014/12000/Dete
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/FTD.0000000000000095DOI Listing
December 2014

An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.

J Pharm Biomed Anal 2014 Nov 4;100:254-261. Epub 2014 Aug 4.

EA4553, Université Paul Sabatier Toulouse III, Toulouse F-31000, France; Institut Claudius Regaud, IUCT-O, Laboratoire de pharmacologie, 1 Avenue Joliot-Curie, Toulouse F-31059, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2014.07.033DOI Listing
November 2014

Therapeutic drug monitoring in cancer--are we missing a trick?

Eur J Cancer 2014 Aug 27;50(12):2005-9. Epub 2014 May 27.

Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Stotervaart Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.04.013DOI Listing
August 2014

Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.

Eur J Cancer 2014 Aug 2;50(12):2010-9. Epub 2014 Jun 2.

EA4553 Institut Claudius-Regaud, Université Paul-Sabatier, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.04.014DOI Listing
August 2014

Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies.

Eur J Cancer 2014 Aug 10;50(12):2020-36. Epub 2014 Jun 10.

Department of Pharmacy, CNRS-UMR 7054, School of Medicine Paris 12, Henri Mondor University Hospitals, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.04.015DOI Listing
August 2014

Pharmacokinetics of pazopanib administered in combination with bevacizumab.

Cancer Chemother Pharmacol 2014 Jun 6;73(6):1189-96. Epub 2014 Apr 6.

EA4553 Institut Claudius-Regaud, Université de Toulouse, 20, rue du Pont-Saint-Pierre, 31052, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2455-3DOI Listing
June 2014

Standardization of chemotherapy and individual dosing of platinum compounds.

Anticancer Res 2014 Jan;34(1):465-70

Institut Claudius-Regaud and EA4553, University of Toulouse, France.

View Article

Download full-text PDF

Source
January 2014

Model-based approach to describe G-CSF effects in carboplatin-treated cancer patients.

Pharm Res 2013 Nov 26;30(11):2795-807. Epub 2013 Jun 26.

Unité de Médecine, Urgences Soins Intensifs, Université de Toulouse, INP, Ecole Nationale Vétérinaire de Toulouse, 31076, Toulouse, France,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11095-013-1099-zDOI Listing
November 2013

Application of hematological toxicity modeling in clinical development of abexinostat (S-78454, PCI-24781), a new histone deacetylase inhibitor.

Pharm Res 2013 Oct 5;30(10):2640-53. Epub 2013 Jun 5.

Clinical Pharmacokinetics Department, Institut de Recherches Internationales Servier, 50 rue Carnot, 92284, Suresnes Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11095-013-1089-1DOI Listing
October 2013

Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?

Cancer Chemother Pharmacol 2013 Feb 27;71(2):531-6. Epub 2012 Nov 27.

EA4553 Laboratoire de Pharmacocinétique, Institut Claudius-Regaud, Université de Toulouse, 31052 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-012-2035-3DOI Listing
February 2013

Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC-MS/MS assay and ultrafiltration method.

J Chromatogr B Analyt Technol Biomed Life Sci 2012 Oct 7;907:94-100. Epub 2012 Sep 7.

EA4553, Laboratoire de Pharmacocinétique, Institut Claudius Regaud, 31052 Toulouse, France.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S157002321200527
Publisher Site
http://dx.doi.org/10.1016/j.jchromb.2012.09.007DOI Listing
October 2012

[Pharmacology of platinum compounds: differences between the three molecules and factors of interpatient variability].

Authors:
Etienne Chatelut

Bull Cancer 2011 Nov;98(11):1253-61

Université de Toulouse, institut Claudius-Regaud, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2011.1464DOI Listing
November 2011

[Pharmacokinetics and impaired organic functions].

Authors:
Etienne Chatelut

Bull Cancer 2011 Nov;98(11):1347-54

Université de Toulouse, institut Claudius-Regaud, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2011.1465DOI Listing
November 2011

Pharmacogenetic tailoring of irinotecan-based first-line chemotherapy in metastatic colorectal cancer: results of a pilot study.

Anticancer Res 2011 Jan;31(1):359-66

Université de Lyon and Department of Medical Oncology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.

View Article

Download full-text PDF

Source
January 2011

[Level of evidence for therapeutic drug monitoring of cisplatin].

Therapie 2010 May-Jun;65(3):151-5. Epub 2010 Aug 11.

CHU Henri Mondor, AP-HP, Université Paris XII, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie/2010022DOI Listing
October 2010

[Level of evidence for therapeutic drug monitoring of carboplatin].

Therapie 2010 May-Jun;65(3):157-62. Epub 2010 Aug 11.

CHU Henri Mondor, AP-HP, Université Paris XII, Créteil, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie/2010021DOI Listing
October 2010

Quantification of topotecan by liquid chromatography-mass spectrometry (LC-MS). Application to intestinal transport using rat everted gut sacs.

J Chromatogr B Analyt Technol Biomed Life Sci 2010 Mar 25;878(7-8):645-52. Epub 2010 Jan 25.

EA3035 Clinique et Expérimentale de Médicaments Anticancereux, Institut Claudius Regaud, 31052 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2010.01.019DOI Listing
March 2010

[Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].

Bull Cancer 2009 Dec;96(12):1243-52

Departement de Chirurgie Oncologique, EA3035, Departement d'Anatomo-Pathologie, Université de Toulouse, Departement d'Oncologie Médicale Institut Claudius-Regaud, 20-24 Rue du Pont-Saint-Pierre, 31052 Toulouse Cedex.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2009.1005DOI Listing
December 2009

Pharmacokinetics of rituximab associated with CHOP chemotherapy in B-cell non-Hodgkin lymphoma.

Fundam Clin Pharmacol 2009 Oct 29;23(5):601-8. Epub 2009 Jul 29.

Université François Rabelais de Tours; CHRU de Tours, laboratoire de pharmacologie et toxicology, 37044 Tours cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1472-8206.2009.00714.xDOI Listing
October 2009

Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma.

Eur J Cancer 2009 Sep 10;45(13):2316-23. Epub 2009 Jun 10.

EA3035 and Université de Toulouse, Laboratoire de Pharmacologie Clinique et Expérimentale des Médicaments Anticancéreux, 20-24, F-31052 Toulouse, Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2009.05.007DOI Listing
September 2009

Human renal function maturation: a quantitative description using weight and postmenstrual age.

Pediatr Nephrol 2009 Jan 10;24(1):67-76. Epub 2008 Oct 10.

Department of Pharmaceutical Biosciences, Division of Pharmacokinetics and Drug Therapy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00467-008-0997-5DOI Listing
January 2009

Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.

AIDS 2009 Jan;23(2):257-9

CHU Rangueil, Department of Clinical Physiology and Université Toulouse III Paul Sabatier, Toulouse, France.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00002030-200901140-000
Publisher Site
http://dx.doi.org/10.1097/QAD.0b013e328314e382DOI Listing
January 2009

Population approaches in paediatrics.

Authors:
Etienne Chatelut

Fundam Clin Pharmacol 2008 Dec;22(6):575-8

Institut Claudius-Regaud, EA3035 Université de Toulouse, F-31052 Toulouse cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1472-8206.2008.00647.xDOI Listing
December 2008

[Anticancer drug dose individualisation: from body surface area to physiology].

Bull Cancer 2008 Oct;95(10):895-901

Institut Claudius-Regaud et EA3035, Université de Toulouse, 20, rue du Pont-Saint-Pierre, 31052 Toulouse cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2008.0720DOI Listing
October 2008

Modeling the variability of creatinine measurements improves estimates of the glomerular filtration rate.

Clin Chem Lab Med 2008 ;46(2):215-8

Department of Clinical Biology, Institut Claudius Regaud, Université Paul Sabatier, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2008.045DOI Listing
May 2008

Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.

Photochem Photobiol Sci 2008 Apr 14;7(4):433-41. Epub 2008 Feb 14.

Centre de Recherche en Automatique de Nancy, Nancy-University, CNRS, Centre Alexis Vautrin, Brabois, Avenue de Bourgogne, F-54511, Vandoeuvre-lès-Nancy Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/b718259gDOI Listing
April 2008

Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study.

Ann Surg Oncol 2008 Jan 18;15(1):339-44. Epub 2007 Oct 18.

Department of Surgical Oncology, Institut Claudius Regaud, 20-24 Rue du Pont Pierre, 31052, Toulouse, Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-007-9571-9DOI Listing
January 2008

Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinoma.

Clin Cancer Res 2007 Dec;13(23):7086-92

Laboratoire de Pharmacologie Clinique et Expérimentale des Médicaments Anticancéreux, EA3035, Institut Claudius Regaud, Université Paul Sabatier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-1370DOI Listing
December 2007

Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese.

J Clin Oncol 2007 Oct;25(30):4707-13

Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.2938DOI Listing
October 2007

[Interest of cystatin C for individual dosing of anticancer drugs cleared by the kidneys].

Therapie 2007 Mar-Apr;62(2):121-7. Epub 2007 Jun 21.

Institut Claudius-Regaud, EA3035 Pharmacologie Clinique et Expérimentale des Médicaments Anti-Cancéreux, et UFR de Pharmacie, Université Paul-Sabatier, 20-24 rue du Pont Saint Pierre, 31052 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2515/therapie:2007019DOI Listing
September 2007

GFR is better estimated by considering both serum cystatin C and creatinine levels.

Pediatr Nephrol 2006 Sep 22;21(9):1299-306. Epub 2006 Jun 22.

Department of Clinical Biology and EA3035, Institut Claudius-Regaud, Toulouse, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00467-006-0145-z
Publisher Site
http://dx.doi.org/10.1007/s00467-006-0145-zDOI Listing
September 2006

Population pharmacokinetic-pharmacodynamic model for neutropenia with patient subgroup identification: comparison across anticancer drugs.

Clin Cancer Res 2006 Sep;12(18):5481-90

Department of Clinical Pharmacy, Institute of Pharmacy, Freie Universitaet Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0815DOI Listing
September 2006

Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patients.

Med Oncol 2006 ;23(1):63-73

Department of Clinical Biology, Institute Claudius Regaud, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/MO:23:1:63DOI Listing
June 2006